• Skip to main content
  • Skip to secondary menu
  • Skip to footer

ESN.net

Short posts on anything worth a second look.

  • Sponsored Post
  • About
    • GDPR
  • Contact

SynBioBeta 2019: Pioneers of tech and biology will take the stage at synthetic biology’s premier industry event, October 1-3 2019, San Francisco

September 23, 2019 By admin Leave a Comment

Eric Schmidt, former CEO and Chairman of Google, will take the stage at SynBioBeta 2019, the leading industry conference bringing together biological engineers, investors, innovators, and entrepreneurs to build a better world with biology. Mr. Schmidt will be joined by George Church, a groundbreaking researcher and leading voice in synthetic biology. The two will explore advances in biology and technology — a field known as synthetic biology — and how it can lead to human progress and a new bio-industrial revolution.

Eric Schmidt is one of the world’s most successful business leaders. As CEO of Google from 2001 to 2011, he is arguably one of the Internet’s most important people. Mr. Schmidt is also a well-known philanthropist, particularly in the areas of science and natural resources. In 2010 he co-founded Innovation Endeavors, an early-stage venture capital firm that believes recent advances in science and technology will create exponential rates of change and emergent ecosystems in a new world.

George Church is Professor of Genetics at Harvard Medical School and Massachusetts Institute of Technology (MIT). Dr. Church is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. He developed the first direct genomic sequencing method and helped initiate the Human Genome Project, leading to a revolution in science and medicine whose impact is still being realized.

SynBioBeta will also recognize three individuals’ significant contributions to the synthetic biology field.

Nobel Laureate Frances Arnold of Caltech will be recognized as a Pioneer in Synthetic Biology for her groundbreaking work in engineering biology to evolve useful enzymes for a more sustainable planet.

Twist Biosciences CEO Emily Leproust and her company are being recognized for IPO of the Year, following a very successful public offering and performance this year.

Megan Palmer will be recognized by SynBioBeta for Biostrategy and Leadership for her ongoing work to explore emerging safety and security practices as biotechnology becomes mainstream.

Other speakers at the industry’s premier annual event include Space Station Commander Tim Kopra, synthetic biology legend Drew Endy, Daphne Koller of insitro, Senti Biosciences’ Timothy Lu, Oliver Morton of The Economist, Karin Strauss of Microsoft, and Chief Economic and Business Advisor to Governor Gavin Newsom, Lenny Mendonca.

“Visionaries like Frances Arnold, Eric Schmidt, and George Church are the best people in the world to show us how to build a better world with biology,” said SynBioBeta founder and CEO John Cumbers. “Synthetic biology is ready to turn today’s industry on its head and revolutionize the way we do business. In the same way that every company today is in some way an Internet company, every company will one day be a biology company. With insights from the likes of these tech and bio-pioneers, SynBioBeta 2019 is the place to get ahead of the curve.”

This year’s conference will explore how engineered biology will disrupt consumer products, food, agriculture, medicine, chemicals, materials, and more. Talks and panels will examine how the future will be written in DNA, how synthetic biology can improve agriculture and re-balance the nitrogen cycle, what investment opportunities exist throughout the industry, and why all companies need to create a biostrategy to stay competitive in the coming bioeconomy.

About SynBioBeta. SynBioBeta is the leading community of innovators, investors, engineers, and thinkers who share a passion for using synthetic biology to build a better, more sustainable universe. We create and energize innovation communities to make the impossible possible via unparalleled opportunities for growth, networking, storytelling, and learning.

Through international synthetic biology conferences and events that bring the entire community together throughout the year, we give innovators the opportunity to meet with other bright minds building and shaping the bioeconomy. We showcase cutting-edge synthetic biology research and technologies that are transforming how we feed, fuel, heal, and build the world.

SynBioBeta offers a weekly industry digest, a podcast, a quarterly magazine (coming soon), and educational courses. We also provide our world-class partners with opportunities for advertising, partnership, trade show exhibition, strategic consultation, and promotion. For more information, visit www.synbiobeta.com.

SOURCE SynBioBeta
https://synbiobeta.com

Filed Under: events Tagged With: SynBioBeta, biotech

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • The $931 Million Insider Signal the Quantum Bubble Can No Longer Hide
  • TechSummit.net
  • Why We Love Orchids
  • Turning Attention Into Opportunity
  • Arearea (Joyeusetés), 1892 — Gauguin’s dream of Tahiti as a constructed paradise
  • Une rue à Paris en mai 1871 — Luce’s memory of a city after rupture
  • Jean-Léon Gérôme, The Gladiators and the Modern Gaze on Rome, Musée d’Orsay, Paris
  • Garamendi Blasts Trump’s FY27 Budget as a War Budget Disguised as Fiscal Policy
  • The Sports Rights Bubble and Where It Breaks
  • India’s Moment and Why It Keeps Getting Delayed

Media Partners

  • JVQ.net: Just Very Quick
  • k4i.com
  • Referently.com
Valerian for Stress: Weak Evidence, Mild Risk, Oversold Promise
Quantum Computing’s $931 Million Insider Sell-Off Is the Bubble Warning Wall Street Can’t Ignore
Quantum Stocks Are Starting to Look Like the Next Meme Stock Bubble
AI’s Next Market Shockwave Is Coming: AMD, Broadcom, and NVIDIA Earnings Are Around the Corner
EDC Las Vegas 2026: What Attendees Need to Know Before the Weekend
Danielle Deadwyler and the Problem of Being the Best Thing in Every Room
The Crawford-Mayweather Debate Is a Question Boxing Cannot Answer
Did Sean Strickland Win?
A Man with a Gun Ran Through the White House Correspondents' Dinner. The Aftermath Was Predictable.
Trump Called Norah O'Donnell a Disgrace on Live TV. He Was Not Wrong.
The KOSPI's 5.5% Friday: Concentration Comes Due as the Semiconductor Trade Reprices
Quantinuum (QNT) Falls Below Its $60 IPO Price as Revenue Shrinks 73%
The SOX Fell 10.26% on June 5: Semiconductors Are Unlikely to Round-Trip to the Highs Next Week
SpaceX at $1.75 Trillion: The IPO That Reprices the Whole Market
May CPI, June 10: Four Reaction Scenarios and the Asymmetry Working Against the Bulls
Markets Week Ahead: May CPI on June 10, SpaceX Lists June 12, and the Nvidia Verdict That Waits Until August
Nvidia Clears Memory's Big Three for Vera Rubin HBM4 Supply
Qualcomm and the AI Infrastructure Boom: A 62% Rally Ahead of the Revenue
Berkshire's $10 Billion Alphabet Buy Is a Signal, Not a Trade: The AI Build-Out Is Just Getting Started
Marvell Q1 FY2027: The $15 Billion Number Behind the Beat
Mesh WiFi vs Access Points: Which Architecture Is Right for Your Home
802.11r, 802.11k, 802.11v: The Three Protocols That Make WiFi Roaming Seamless
60 GHz WiGig Is Not Dead: Here Is Where It Actually Makes Sense
Why Your WiFi Router Should Never Be on the Floor
What People Actually Build With a Raspberry Pi: Case Studies From the Field
MOPP Levels
Perihelion and Aphelion
Going Concern Opinion
Holograph Manuscript
Finding Aid

Media Partners

  • Media Presser
  • 3V.org
  • Press Club US
MarketAnalysis.com Publishes Comprehensive Quantum Computing Equity Memo Covering IONQ, QBTS, RGTI, QUBT, XNDU, INFQ
What Is an Analyst Call
Foreign Debt Holdings Are a Trade Deficit Problem, Not Just a Fiscal One
Why Belgium Holds More U.S. Debt Than Saudi Arabia, and What That Actually Means
Private Investors Now Dominate Foreign Holdings of U.S. Treasury Debt
The United States Paid $282 Billion in Interest to Foreign Debt Holders in 2025
NAB 2026: Las Vegas and the End of the Broadcast Era
Japan Holds $1.185 Trillion in U.S. Debt and the Number Tells an Incomplete Story
Foreign Holdings of U.S. Federal Debt Reached $9.2 Trillion in 2025
China Has Shed $357 Billion in U.S. Treasuries Since 2021
Barilla Opens Good Food Makers 2026 Applications Through July 10
The Future Is Here, Just Not Equally Distributed
Westin Grand Central, Three Days in May: The 21st Needham Technology, Media & Consumer Conference
SpaceX Launch Cadence and the New Normal in American Rocketry
Self-Checkout Is Failing and Retailers Are Starting to Admit It
Sam Altman, xAI, and the AI Industry's Accountability Deficit
Pete Hegseth and the Pentagon's Leadership Vacuum
Kentucky Derby 2026: What the Result Tells You
Why Spirit Airlines Shut Down
Harley-Davidson's 2024–2026 Recall and What It Signals
The DOJ's Comey Campaign Is Costing It Prosecutors
Judge Dismisses Ray Epps Defamation Case Against Fox News a Second Time
Iran Sits on UN Boards for Women's Rights, Nonproliferation, and Counterterrorism
Congress Moves to Protect Whales in San Francisco Bay with Save Willy Act
Palantir, DHS, and the Growing Fight Over Immigration Surveillance
Migration and the Limits of European Identity
The Security Subsidy: Why European Rearmament Remains Stalled
Rubio: If NATO Bars Us From Using Our Own Bases, It's a One-Way Street
Oil Flows Disrupted: Ukraine Strikes Hit Russia’s Baltic Export Arteries
Industrial Darwinism on the Battlefield: Ukraine’s Drone War Is Forcing a Rethink

Copyright © 2026 ESN.net

Media Partners: Market Analysis · Market Research · Referently · Photography